» Articles » PMID: 18761966

The Epidemiology of Hepatitis C Virus Infection in Sweden

Overview
Journal Euro Surveill
Date 2008 Sep 3
PMID 18761966
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

In Sweden, infection with hepatitis C virus (HCV) has been a notifiable disease since 1990, when diagnostic methods became available. Blood donor screening indicated that about 0.5% of the Swedish population (9 millions) had been HCV infected. Here we present the Swedish hepatitis C epidemic based on data from all the HCV notifications 1990-2006. During this time about 42,000 individuals (70% men) were diagnosed and reported as HCV infected. The majority (80%) were born in 1950 or later, with a high percentage (60%) born in the 1950s and 1960s. Younger people, 15-24 years old at notification, were reported on the same level each year. The main reported routes of HCV transmission were intravenous drug use in 65%, blood transfusions/products in 6%, and sexual in 2%, though unknown or not stated in 26%. Approximately 6,000 of all notified individuals have died during the study period. To conclude, the Swedish HCV epidemic is highly related to the increase of intravenous drug use in the late 1960s and 1970s, with a high proportion of people now chronically infected for more than 25 years, resulting in an increase of severe liver complications in form of cirrhosis and hepatocellular carcinoma. Furthermore the unchanged number of notifications of newly infected younger people indicates an ongoing HCV epidemic.

Citing Articles

Hepatitis C time trends in reported cases and estimates of the hidden population born before 1965, Denmark and Sweden, 1990 to 2020.

Christensen P, Debrabant B, Cowan S, Debrabant K, Ovrehus A, Duberg A Euro Surveill. 2023; 27(50).

PMID: 36695470 PMC: 9808318. DOI: 10.2807/1560-7917.ES.2022.27.50.2200243.


Liver-related effects of chronic hepatitis C antiviral treatment.

Laursen T, Sandahl T, Kazankov K, George J, Gronbaek H World J Gastroenterol. 2020; 26(22):2931-2947.

PMID: 32587440 PMC: 7304101. DOI: 10.3748/wjg.v26.i22.2931.


Lower risk of multiple sclerosis in patients with chronic hepatitis C: a nationwide population-based registry study.

Soderholm J, Yilmaz A, Svenningsson A, Busch K, Wejstal R, Brolund A J Neurol. 2019; 266(9):2208-2215.

PMID: 31152298 PMC: 6687702. DOI: 10.1007/s00415-019-09397-8.


Risk behaviour determinants among people who inject drugs in Stockholm, Sweden over a 10-year period, from 2002 to 2012.

Karlsson N, Santacatterina M, Kall K, Hagerstrand M, Wallin S, Berglund T Harm Reduct J. 2017; 14(1):57.

PMID: 28814336 PMC: 5559856. DOI: 10.1186/s12954-017-0184-8.


Prevalence and risk factors for HIV, hepatitis B, and hepatitis C in people with severe mental illness: a total population study of Sweden.

Bauer-Staeb C, Jorgensen L, Lewis G, Dalman C, Osborn D, Hayes J Lancet Psychiatry. 2017; 4(9):685-693.

PMID: 28687481 PMC: 5573766. DOI: 10.1016/S2215-0366(17)30253-5.